GrishamJ., “New Rules for Gene Patents”Nature Biotechnology18, no. 9 (2000): at 921; GitterD.M., “International Conflicts Over Patenting Human DNA Sequences in the United State and the European Union: An Argument for Compulsory Licensing and a Fair-Use Exemption,”New York University Law Review76 (2001): at 1624; PollackA., “U.S. Hopes to Stem Rush Toward Patenting Genes,”The Patriot Ledger (Quincy, MA), June 29, 2002: at 18.
3.
Grisham, supra note 2, at 921.
4.
Grisham, supra note 2, at 921.
5.
Grisham, supra note 2, at 50.
6.
ResnikD. B., Owning the Human Genome; A Moral Analysis of DNA Patenting (Albany, NY: SUNY Press, 2004): at 51.
ResnikD. B., “DNA Patents and Human Dignity”Journal of Law, Medicine & Ethics29, no. 2 (2001): 152–65.
21.
Resnik, supra note 6, at 129.
22.
Resnik, supra note 6, at 196
23.
Resnik, supra note 6, at 196.
24.
Resnik, supra note 6, at 196.
25.
Resnik, supra note 6,. at 201.
26.
Resnik, supra note 6,. at 65.
27.
Resnik, supra note 6, at 65.
28.
Resnik, supra note 6, at 83–84.
29.
Resnik, supra note 6, at 197.
30.
Resnik, supra note 6, at 197.
31.
Resnik, supra note 6, at 200.
32.
See, e.g., PitcherA.S., “Contrary to First Impression, Genes are Patentable: Should there be Limitations?”Journal of Health Care Law and Policy6 (2003): at 284; HornM. E., “DNA Patenting and Access to Healthcare: Achieving the Balance Among Competing Interests,”Cleveland State Law Review50 (2003): at 253; LissyN. A., “Patentability of Chemical and Biotechnology Inventions: A Discrepancy in Standards,”Washington University Law Quarterly81 (2003): at 1069.
